Archives of Academic Emergency Medicine

Vol. 13 No. 1 (2025)

Neurological Crisis Following Intravenous Ozone Therapy; a Case Report

Archives of Academic Emergency Medicine, Vol. 13 No. 1 (2025), 6 Shahrivar 2025 , Page e31
https://doi.org/10.22037/aaemj.v13i1.2592

Abstract

Ozone therapy, often marketed as an immune-boosting alternative treatment, lacks robust evidence of efficacy and poses significant safety risks. Despite claims of therapeutic benefits, Regulatory agencies, such as the U.S. Food and Drug Administration (FDA), warn against its use due to its toxic properties and lack of proven benefits at tolerable exposure levels. This case report highlights severe neurological complications, including ischemic infarcts and persistent cognitive deficits, following intravenous ozone (O3) therapy in a previously healthy patient. A 36-year-old woman presented to the emergency department with chest pain, syncope, and generalized seizure shortly after receiving intravenous ozone therapy. Diagnostic imaging revealed multiple ischemic infarcts in the thalamus and cerebellum, consistent with an embolic event. The patient required intensive care unit (ICU) admission, and despite improved neurological function experienced lasting cognitive impairments necessitating long-term rehabilitation.

Keywords:
  • Embolism, Air
  • Complementary Therapies
  • Emergency Service
  • Hospital
  • Neurology
  • Ozone

How to Cite

1.
Wong CYY, Saxena K, Meneer J, George K, Keijzers G. Neurological Crisis Following Intravenous Ozone Therapy; a Case Report. Arch Acad Emerg Med [Internet]. 2025 Jan. 21 [cited 2026 Jul. 7];13(1):e31. Available from: https://journals.sbmu.ac.ir/aaem/index.php/AAEM/article/view/2592

References

Bocci V, Borrelli E, Travagli V, Zanardi I. The ozone paradox: ozone is a strong oxidant as well as a medical drug. Med Res Rev. 2009;29(4):646-82.

Code of Federal Regulations NA. Electronic Code of Federal Regulations. CFR - Code of Federal Regulations Title 21. 21CFR801.415. U.S. Food and Drug Administration.: Code of Federal Regulations, National Archives 2024 [updated 27th December 2024 Available from: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-801/subpart-H/section-801.415.

Haggiag S, Prosperini L, Stasolla A, Gerace C, Tortorella C, Gasperini C. Ozone-induced encephalopathy: A novel iatrogenic entity. Eur J Neurol. 2021;28(8):2471-8.

Sepehr K, Zahra M. Cerebral gas embolism and multifocal ischemic stroke during oxygen-ozone therapy: a case report. BMJ Neurology Open. 2024;6(2):e000885.

Holm SM, Balmes JR. Systematic Review of Ozone Effects on Human Lung Function, 2013 Through 2020. Chest. 2022;161(1):190-201.

Ruidavets JB, Cournot M, Cassadou S, Giroux M, Meybeck M, Ferrières J. Ozone air pollution is associated with acute myocardial infarction. Circulation. 2005;111(5):563-9.

Jiang Y, Huang J, Li G, Wang W, Wang K, Wang J, et al. Ozone pollution and hospital admissions for cardiovascular events. Eur Heart J. 2023;44(18):1622-32.

Serra MEG, Baeza-Noci J, Mendes Abdala CV, Luvisotto MM, Bertol CD, Anzolin AP. The role of ozone treatment as integrative medicine. An evidence and gap map. Front Public Health. 2022;10:1112296.

Murphy RP, Donnellan J. A High-pressure Solution for a High-pressure Situation: Management of Cerebral Air Embolism with Hyperbaric Oxygen Therapy. Cureus. 2019;11(9):e5559.

  • Abstract Viewed: 649 times
  • pdf Downloaded: 1265 times

Download Statastics

Make a Submission

Make a Submission

SJR

SCImago Journal & Country Rank

COPE

Current Issue

Information